Merck Valuation
| MRK Stock | MXN 2,015 21.44 1.05% |
At this time, the firm appears to be overvalued. Merck Company secures a last-minute Real Value of 1591.86 per share. The latest price of the firm is 2015.01. Our model forecasts the value of Merck Company from analyzing the firm fundamentals such as Profit Margin of 0.24 %, current valuation of 5.9 T, and Return On Equity of 0.35 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Merck's price fluctuation is very steady at this time. Calculation of the real value of Merck Company is based on 3 months time horizon. Increasing Merck's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Merck is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merck Stock. However, Merck's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2015.01 | Real 1591.86 | Hype 2015.01 |
The intrinsic value of Merck's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Merck's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Merck Company helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck more accurately as focusing exclusively on Merck's fundamentals will not take into account other important factors: Merck Total Value Analysis
Merck Company is now forecasted to have takeover price of 5.9 T with market capitalization of 5.17 T, debt of 30.69 B, and cash on hands of 7.1 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Merck fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.9 T | 5.17 T | 30.69 B | 7.1 B |
Merck Investor Information
About 76.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.34. Merck Company recorded earning per share (EPS) of 107.29. The entity last dividend was issued on the 14th of March 2023. Merck Company is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Merck Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Merck has an asset utilization ratio of 56.09 percent. This suggests that the Company is making 0.56 for each dollar of assets. An increasing asset utilization means that Merck Company is more efficient with each dollar of assets it utilizes for everyday operations.Merck Ownership Allocation
Merck Company maintains a total of 2.54 Billion outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Merck Profitability Analysis
The company reported the revenue of 59.28 B. Net Income was 14.52 B with profit before overhead, payroll, taxes, and interest of 44.14 B.About Merck Valuation
Our relative valuation model uses a comparative analysis of Merck. We calculate exposure to Merck's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck's related companies.It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 69000 people.
8 Steps to conduct Merck's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Merck's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Merck's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Merck's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Merck's revenue streams: Identify Merck's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Merck's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Merck's growth potential: Evaluate Merck's management, business model, and growth potential.
- Determine Merck's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Merck's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Merck Stock Analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.